Spots Global Cancer Trial Database for Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
Official Title: Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell
Study ID: NCT00156858
Conditions
Interventions
Study Description
Brief Summary: A study of pharmacokinetics of daily intravenous busulfan
Detailed Description: A study of pharmacokinetics of daily intravenous busulfan
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Contact Details
Name: James Russell, FRCp
Affiliation: Alberta Cancerboard
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
